Moderna Inc said on Sunday it has received an additional $472 million from the U.S. government’s Biomedical Advanced Research and Development Authority (BARDA) to support the development of its novel coronavirus vaccine. The U.S.-based drugmaker said the additional funding will support its late-stage clinical development including the expanded Phase 3 …
Read More »